Abstract:Multiple myeloma (MM) is an incurable B-cell malignancy. High-dose chemotherapy with stem cell support has achieved higher response rates than conventional therapy, but few patients remain in long-term remission. Arsenic trioxide (As2O3) is an effective treatment for acute promyelocytic leukemia. Current clinical studies are investigating arsenic as a therapeutic agent for malignancies. The mechanism of cytotoxicity inducted by As2O3 has not been known thoroughly. Constitutively activated NF-κB is a characteristic of different tumor entities including MM clones and malignant plasma cells from MM patients. It plays an important role in maintaining tumor cell proliferation and protecting cell from apoptosis. The study was to explore the possible mechanism of As2O3 effects on MM lines. Materials and methods: The human MM cell lines of KM3 and RPMI8226 were provided by Hematology Institution of Zhejiang University. The concentration of As2O3 in cell culture system was from 0.5μmol/L to 20μmol/L, 24 hours was selected as the termination point of cell culture. Cell culture without As2O3 and first-antibody-dismissed test were enrolled as controls. Both of the MM lines were treated with As2O3 in various concentrations. The restrained proliferation was observed by drawing growth curve. MTT bioassay was used to examine the effect of As2O3 on cell growth and the concentration of 50% growth inhibition( IC50) calculated respectively. Apoptosis and changes of IκB-α protein was observed by flow cytometry(FCM). Changes and subcellular localization of IκB-α protein were observed by fluorescence microscopy. Western blot was also used to analyze the expression of NF-κB in nuclear. Results: As2O3 inhibited the proliferation of both MM lines, and IC50 of KM3 and RPMI8226 was 9.61μmol/L and 8.01μmol/L respectively. After exposure to As2O3, both of the lines were induced to apoptosis. With As2O3 concentration varied from 0.5μmol/L to 20μmol/L the apoptosis rate of KM3 and RPMI8226 was concentration-dependent measured by FCM. After 24 hours treated with 20μmol/L As2O3, the apoptosis rate of KM3 cells was 41.18% while that of RPMI8226 was 65.25%. It seemed that RPMI8226 cell was more sensitive to As2O3. FCM analysis showed a significant increase in the percentage of G2/M phase cells, from 13.74% to 41.72%, and a decrease percentage of S phase cells from 35.11% to 23.96%. The level of IκB-α in cytoplasm was down-regulated after As2O3 stimulation in both cell lines. The down-regulation of IκB-α from 79.68% to 51.57% was confirmed by FCM in KM3 treated with 10μmol/L As2O3 (p<0.01), the effect was concentration-dependent. While the IκB-α in RPMI8226 changed from 79.72% to 34.08% (p<0.01). Immunofluorescence assay showed that IκB-α localized in cytoplasm mostly. The level of IκB-α protein was down-regulated after As2O3 stimulation. The results showed that KM3 and RPMI8226 lines expressed constitutively activity NF-κB and As2O3 down-regulated the constitutive expression of NF-κB in both cell lines but with different kinetics. Conclusions: As2O3 could not only inhibit the proliferation but also induce apoptosis of KM3 and RPMI8226 cells. The mechanisms of its effect on MM cells may include decreasing the constitutive activity of NF-κB, subsequently down-regulating the expression of various gene products controlled by NF-κB, thus inducing apoptosis in MM cells. As2O3 could inhibit the proliferation of MM cells by changing MM cell cycle and inducing G2/M phase arrest.

[Realgar Nano-Particles Induce Apoptosis and Necrosis in Leukemia Cell Lines K562 and HL-60].

[Apoptosis effects of drug sensitivity leukemia cells induced by nano-realgar]

Silver Nanoparticles Induce Apoptosis in HepG2 Cells through Particle-Specific Effects on Mitochondria

Arsenic Trioxide Induces Not Only Apoptosis but Also Autophagic Cell Death in Leukemia Cell Lines Via Up-Regulation of Beclin-1

Preparation Of Realgar Nanoparticle Suspension And Its Inhibition Effect On The Proliferation Of Human Myelocytic Leukaemia Hl-60 Cells

Toxicity of nano- and micro-sized silver particles in human hepatocyte cell line L02

[Relationship Between Drug Resistance and the Expression of NF-kappaB Induced in Leukemic Cells].

In Vitro Cytotoxicity And Oxidative Damage Effect Of Silver Nanoparticles On Hl-7702 Cells

[Differentiation of HL-60 Cells Induced by Realgar Nano-Particles].

Mechanism Of Arsenic Trioxide-Induced Apoptosis On Multiple Myeloma Cells.

Roles of PI3-K/Akt Pathways in Nanoparticle Realgar Powders-Induced Apoptosis in U937 Cells

Realgar-induced differentiation is associated with MAPK pathways in HL-60 cells.

Anticancer Effect of Realgar Nanoparticles on Mouse Melanoma Skin Cancer in Vivo Via Transdermal Drug Delivery

Realgar (As4S4), a traditional Chinese medicine, induces acute promyelocytic leukemia cell death via the Bcl-2/Bax/Cyt-C/AIF signaling pathway in vitro

Trivalent Methylated Arsenic Metabolites Induce Apoptosis in Human Myeloid Leukemic HL-60 Cells Through Generation of Reactive Oxygen Species

The Cellular Uptake and Cytotoxic Effect of Silver Nanoparticles on Chronic Myeloid Leukemia Cells.

Induction of Human Promyelocytic Leukemia HL-60 Cell Differentiation into Monocytes by Arsenic Sulphide: Involvement of Serine/threonine Protein Phosphatases.

Arsenic Nanoparticles Trigger Apoptosis via Anoikis Induction in OECM-1 Cells

Anti-leukemia Activity of PVP-coated Silver Nanoparticles Via Generation of Reactive Oxygen Species and Release of Silver Ions.

Fe3O4 nanoparticles with daunorubicin induce apoptosis through caspase 8-PARP pathway and inhibit K562 leukemia cell-induced tumor growth in vivo.

Abstract 2110: Realgar Exerts Cytotoxic Killing of Gastric Cancer Cells Through Bax Apoptotic Pathway.